Hyperthyroidism

Detailed Overview

It accelerates the body's metabolism, causing unintentional weight loss and rapid/irregular heartbeat. In toxic nodular goiter (Plummer's disease), single or multiple adenomas develop activating somatic mutations in the TSH receptor. Unlike Graves' disease, it is not an autoimmune condition and usually lacks extrathyroidal manifestations like orbitopathy.

Epidemiology & Demographics

Prevalence of hyperthyroidism is approx 1.2% in the US. Toxic multinodular goiter is more common in older individuals (>50 years) and in iodine-deficient regions. Women are affected more often than men (approx 3:1 ratio).

Etiological Mechanism

Autonomously functioning thyroid adenomas (Toxic Adenoma) or multiple nodules (Toxic Multinodular Goiter) driven by somatic mutations in the TSH receptor (TSHR) or GNAS genes.

Primary Causes

Toxic multinodular goiter

Toxic adenoma

Graves' disease (for general thyrotoxicosis)

Iodine load (Jod-Basedow phenomenon)

• Advanced Age: Risk of toxic multinodular goiter increases significantly over age 50.
• Iodine Deficiency: Endemic iodine deficiency promotes multinodular goiter development.
• Female Sex: Higher incidence of all thyroid disorders in women.

Somatic mutations in the TSH receptor or the alpha subunit of the stimulatory G protein (Gs-alpha) lead to constitutive activation of the cAMP cascade within thyroid follicular cells. This causes unbridled cellular proliferation (nodule formation) and unregulated synthesis and release of T3 and T4, which in turn profoundly suppress pituitary TSH secretion via negative feedback.

Characteristic Clinical Presentation

• Palpitations: Sensation of a rapid, fluttering, or pounding heart.
• Weight loss: Unintentional weight loss despite increased appetite.
• Heat intolerance: Excessive sweating and feeling hot in normally comfortable environments.
• Tremor: Fine tremor of the hands or fingers.

Physical Examination Signs

• Tachycardia or Atrial Fibrillation (especially in elderly patients)
• Palpable, irregular, nodular thyroid gland (goiter)
• Brisk deep tendon reflexes
• Warm, moist skin

• Atrial Fibrillation: Common in older adults with thyrotoxicosis, risking thromboembolic stroke.
• Osteoporosis: Accelerated bone turnover leads to decreased bone mineral density.
• High-output Heart Failure: Due to persistent tachycardia and hyperdynamic circulation.

Diagnostic Criteria & Guidelines

Suppressed serum TSH (<0.1 mIU/L) with elevated Free T4 and/or Free T3. Radioactive iodine uptake (RAIU) scan showing heterogeneous or focal areas of increased uptake with suppression of the surrounding gland.

Differential Diagnosis

• Graves' Disease
• Subacute Thyroiditis (De Quervain's)
• Anxiety Disorder
• Pheochromocytoma

Laboratory Tests & Biomarkers

• Serum TSH: < 0.1 mIU/L (suppressed)
• Free T4: Elevated (e.g., > 1.8 ng/dL)
• Total T3: Elevated, often disproportionately higher than T4 (e.g., > 200 ng/dL)
• TSH Receptor Antibodies (TRAb): Negative (differentiates from Graves' disease)

Imaging Modalities & Findings

• Thyroid Ultrasound: Multiple nodules of varying echogenicity, sometimes with cystic degeneration or calcifications.
• Radioactive Iodine Uptake (RAIU) Scan: Patchy, uneven uptake (hot nodules) with suppressed background thyroid tissue.

• Subclinical
  Suppressed TSH with normal free T4 and T3 levels, often asymptomatic.
• Overt
  Suppressed TSH with elevated free T4/T3 and typical clinical manifestations.
• Thyroid Storm
  Life-threatening exacerbation with hyperpyrexia, cardiovascular compromise, and altered mentation.

Second-Line & Adjunctive Therapy

Radioactive Iodine (I-131) ablation is the definitive treatment of choice for toxic nodular goiter once euthyroid. Dose typically ranges from 10 to 30 mCi depending on gland size and uptake.

Surgical & Procedural Management

Total or near-total thyroidectomy indicated for large compressive goiters, coexisting thyroid malignancy, or patients declining/contraindicated for RAI. Requires pretreatment with ATDs to achieve euthyroidism to prevent thyroid storm during surgery.

Recommended Lifestyle Changes

• Avoid excessive dietary iodine (e.g., kelp supplements) which can exacerbate hyperthyroidism.
• Maintain adequate calcium and vitamin D intake due to risk of accelerated bone loss.
• Smoking cessation, as it worsens thyroid disease outcomes.

Patient Counseling & Advice

Counsel regarding the risk of agranulocytosis with antithyroid medications (Methimazole); advise immediate cessation and ED evaluation if fever or severe sore throat develops.

Follow-Up & Monitoring Schedule

Free T4 and T3 levels every 4-6 weeks after initiating ATDs. TSH may remain suppressed for months, so dose adjustments should rely on Free T4/T3 initially. Monitor CBC and liver enzymes if symptoms of toxicity occur.

Preventive Strategies

Adequate population-level iodine supplementation prevents endemic multinodular goiter, though rapid iodine supplementation in a deficient population can trigger hyperthyroidism.

Excellent with definitive treatment (RAI or surgery). However, these treatments often lead to permanent hypothyroidism requiring lifelong levothyroxine replacement.